| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5406 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2002-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f020f2c6e34d316408f76413f73a78f |
| publicationDate |
2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2003174894-A |
| titleOfInvention |
Therapeutic agents that are, or contain, antagonists or partial agonists of human interleukin 4, and mutant hIL-4 proteins, and methods for their production |
| abstract |
(57) [Summary] (Modified) [PROBLEMS] To provide a therapeutic agent which is an antagonist (antagonist) or a partial agonist (agonist) of human interleukin 4. The present invention relates to a therapeutic agent which is an antagonist or partial agonist of hIL-4, or which comprises these antagonists or partial agonists, wherein the antagonist or partial agonist is a mutant hIL-4 protein. Achieved by making it available. The choice of therapeutic agent will be in a targeted manner, It has the advantage of using genetic engineering to produce a protein that competes with hIL-4 for occupancy of the hIL-4 receptor because it is similar to wild-type hIL-4. It is a further object of the present invention to make available mutant hIL-4 proteins as well as methods for their production. |
| priorityDate |
1991-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |